| scholarly article | Q13442814 |
| P2093 | author name string | Arnold Ganser | |
| Min Yang | |||
| Michael Heuser | |||
| Guntram Büsche | |||
| Nils von Neuhoff | |||
| Felicitas Thol | |||
| Friedrich Feuerhake | |||
| Zhixiong Li | |||
| Anuhar Chaturvedi | |||
| Kezhi Huang | |||
| Zengkai Pan | |||
| Danian Nie | |||
| P2860 | cites work | The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis | Q24302199 |
| Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3 | Q24311639 | ||
| Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features | Q27026581 | ||
| The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Q27853375 | ||
| Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice | Q28068458 | ||
| Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities | Q28139258 | ||
| An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101 | Q28265615 | ||
| Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis | Q28314922 | ||
| The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase | Q28567919 | ||
| Expression profiling and Ingenuity biological function analyses of interleukin-6- versus nerve growth factor-stimulated PC12 cells | Q28581575 | ||
| Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. | Q30489623 | ||
| Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia | Q30959617 | ||
| Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study | Q33423072 | ||
| Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis | Q33875795 | ||
| Identification of mast cell progenitors in adult mice | Q33914055 | ||
| Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer | Q34460302 | ||
| Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer | Q34501536 | ||
| Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. | Q35119075 | ||
| Human tryptase cleaves pro-nerve growth factor (pro-NGF): hints of local, mast cell-dependent regulation of NGF/pro-NGF action | Q35213103 | ||
| Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling. | Q35641644 | ||
| Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia | Q36223356 | ||
| Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation | Q36403080 | ||
| High-affinity neurotrophin receptors and ligands promote leukemogenesis | Q37116938 | ||
| Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management | Q38358282 | ||
| Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model | Q38800617 | ||
| Nerve growth factor: a neuroimmune crosstalk mediator for all seasons | Q39098815 | ||
| Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. | Q39189663 | ||
| Pathogenesis and Pathology of Mastocytosis | Q40353350 | ||
| Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors | Q40576498 | ||
| Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. | Q40640528 | ||
| Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines | Q40740856 | ||
| Leukemogenic potency of the novel FLT3-N676K mutant | Q40901421 | ||
| Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). | Q41002922 | ||
| Human mast cells express functional TrkA and are a source of nerve growth factor. | Q41085580 | ||
| Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. | Q41612115 | ||
| Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). | Q41636361 | ||
| Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice | Q41939033 | ||
| Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia | Q42538832 | ||
| Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways | Q42804693 | ||
| Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors | Q42804769 | ||
| A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib | Q44534510 | ||
| Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. | Q46262657 | ||
| Resistance of mature T cells to oncogene transformation | Q46357501 | ||
| Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis. | Q46418767 | ||
| Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose | Q47334460 | ||
| Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis | Q47977979 | ||
| Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. | Q48196753 | ||
| Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia. | Q48251471 | ||
| Activation of TRKB receptor in murine hematopoietic stem/progenitor cells induced mastocytosis | Q48603470 | ||
| CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. | Q50484927 | ||
| A transgenic zebrafish model expressing KIT-D816V recapitulates features of aggressive systemic mastocytosis. | Q50651368 | ||
| Interplay between RORgammat, Egr3, and E proteins controls proliferation in response to pre-TCR signals. | Q53617339 | ||
| NFκB and MAPK signalling pathways mediate TNFα-induced Early Growth Response gene transcription leading to aromatase expression. | Q54444540 | ||
| Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. | Q54662841 | ||
| Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene | Q58326964 | ||
| KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients | Q61818977 | ||
| Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis | Q73936505 | ||
| Murine leukemia induced by retroviral gene marking | Q77975543 | ||
| Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA | Q80731905 | ||
| Mast Cells, Mastocytosis, and Related Disorders | Q86622605 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 73871-73883 | |
| P577 | publication date | 2017-05-19 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy | |
| P478 | volume | 8 |
| Q48507286 | Flow cytometric characterization of acute leukemia reveals a distinctive "blast gate" of murine T-lymphoblastic leukemia/lymphoma |
| Q90262410 | Revisiting NTRKs as an emerging oncogene in hematological malignancies |
| Q89839439 | The Role of Mast Cells in IgE-Independent Lung Diseases |
| Q92715334 | The transplantation of human urine stem cells combined with chondroitinase ABC promotes brain-derived neurotrophic factor and nerve growth factor following spinal cord injury in rats |
Search more.